Skip to main content
OpenTrials
Completed

NCT Number: NCT01758757

Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy

Surgical outcome of vitreous surgery for proliferative diabetic retinopathy (PDR) with conventional 20, 23, and 25-gauge vitrectomy were compared.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Proliferative Diabetic Retinopathy

Age range

10 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kyorin Eye Center

Mitaka, Tokyo, 181-8611, Japan

About this study

The 424 eyes of 347 patients of PDR who underwent vitreous surgery for persistent vitreous hemorrhage or progressive proliferative membrane were evaluated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patients of proliferative diabetic retinopathy who underwent vitreous surgery and followed at least 6 months

Exclusion criteria

  • The patients of proliferative diabetic retinopathy who underwent vitreous surgery but did not follow more than 6 months.

Treatment and study plan

Vitrectomy

Procedure

Primary outcomes

  1. Incidence of retinal breaks

    Time frame: One year

Secondary outcomes

  1. Incidence of neovascular glaucoma

    Time frame: One Year

Sponsors and collaborators

Lead sponsor

Kyorin University

Other

Registry information

Official study title

Comparison of Small-gauge and Conventional Vitrectomy for Proliferative Diabetic Retinopathy

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Jan 1, 2013
Registry last updated
Jan 1, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.